FCGR3A has been shown to be involved in multiple immune cell infiltration and DNA mismatch repair genes, while drug sensitivity analysis showed that higher FCGR3A expression predicted lower IC50 (half maximal inhibitory concentration) values for the majority of drugs (21), however, the prognostic value of FCGR3A expression in prostate tumors and its correlation with immune infiltration are unclear. Here, FCGR3A is linked to prostate neoplasm.